Answers are grounded in this paper and cite their sources.
Dear Editor, Delusional infestation (DI) is a condition whereby patients hold a fixed, false belief of being infested with living organisms.1 Patients classically present with excoriated skin at various stages of the healing process, together with ‘evidence’ of their infestation (the specimen sign),2 such as skin debris, insects or insect parts. Patients also complain of a variety of cutaneous symptoms, such as crawling, itching, burning and soreness. DI may occur as a primary disorder or as a consequence of medical illness.3 A significant proportion of patients also have other associated dermatopsychological problems, such as body dysmorphophobia, obsessive compulsive disorder and nodular prurigo. Sufferers often experience significant morbidity and a reduction in quality of life. These symptoms lead to patients seeking the help of their general practitioner (GP), and other healthcare professionals (e.g. dermatologists, psychiatrists and microbiologists), often at significant cost to the National Health Service and with little improvement in their condition. Patients with DI are often difficult to engage and poorly compliant with treatment.4 In this study we demonstrate that seeing patients in a multidisciplinary psychodermatology setting not only improves outcomes, but does so far more cost‐effectively than in either general dermatology services or primary care. A total of 32 consecutive patients who were diagnosed with DI in the period between January 2015 and January 2016 were identified and their medical records were reviewed (including both inpatient and outpatient reports, and also correspondence detailing consultations with GPs and other specialists). Additionally, GPs were contacted in order to obtain further details of each patient relating to GP consultations, medications prescribed and referrals to secondary care. Follow‐up telephone calls were made to each GP practice contacted. Of these 32 patients, the GP records of 23 patients were not able to be accessed in sufficient detail. In total, the primary care records of nine patients were received; however, it was found that one patient had died (from causes unrelated to DI) and therefore this patient was excluded, resulting in a sample of eight patients, for whom sufficient information was available. A comparison of total costings of resources used prior to being referred to our service was conducted. These included looking at a number of GP consultations, investigations and referrals to other specialists. Costings for specific specialist consultations were attained through contacting each respective speciality clinic and enquiring about the costs for initial consultations, follow‐up consultations and also nonattendances. Following a calculation of pre‐ and postpsychodermatology attendance, costs for the average for these eight patients were calculated (see Table 1). Costings for each patient with delusional infestation Values are presented in pounds sterling. GP, general practitioner; NA, not applicable. Costings for each patient with delusional infestation Values are presented in pounds sterling. GP, general practitioner; NA, not applicable. It was found that the average cost prior to attending a dedicated psychodermatology clinic was £854·78 per patient per year, while the average cost of management in the psychodermatology clinic was £359·12 per patient per year. This roughly equates to a 42% reduction overall in treatment costs, indicating that psychodermatology clinics are a cost‐effective service for managing patients with DI. It was also seen that if patients were referred by their GP on their first or second presentation, costs were reduced dramatically. In addition, via telephone consultations with primary care and the patients themselves, we were able to identify that all eight patients had engaged with their treatment and all symptoms of DI had either cleared or were almost cleared. The single patient who died had died from cardiovascular disease unrelated to DI. The management of DI can be challenging, as patients are often reluctant to engage effectively with primary care and mental health clinicians.4 Patients perceive their illness as somatic,5 and seek help from GPs, dermatologists, housing associations and even pest‐control companies, but decline referral to psychiatric services. The collaborative care offered in a dedicated psychodermatology setting allows the patient to access both psychiatric and dermatology expertise along with the support of psychologists and dermatology nurse specialists. Bringing together different skill mixes and recognizing that patients with mental‐health illnesses have other comorbidities that may be social, psychological, psychiatric or physical, is integral to our service. There is still considerable stigma attached to having a mental health illness. Accessing care under the ‘one roof’ of (psycho)dermatology has, in our study, proven to be successful in effectively engaging patients and economically efficient by reducing costs as shown. There is growing evidence to support a collaborative approach to the delivery of clinical care,6 as this is associated with better outcomes, from both a patient and a health economics perspective.7 Our small, but significant, study demonstrates that if a clinician believes that their patient has a delusional infestation then timely referral to an integrated psychodermatology affords the opportunity to manage these patients with better outcomes in a cost‐effective manner. Conflicts of interest: none declared.
No takes yet. Share an insight, caveat, or question.
Altaf et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: